Govt Launches Diabetes Drug Sitagliptin, Its Combinations At Rs 60/pack Of 10
Chief Executive Officer of Pharmaceuticals & Medical Devices Bureau of India (PMBI) Mr Ravi Dadhich launched Sitagliptin a new variant of medicines for diabetes today at affordable prices for all under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana.
PMBI will sell new variants of medicines Sitagliptin and its combination in its all Jan Aushadhi Kendras. The details are as follows:
Name of Product & MRP for Pack of 10
(1) Sitagliptin Phosphate Tablet IP 50mg Rs. 60/-
(2) Sitagliptin Phosphate Tablet IP 100mg Rs. 100/-
(3) Sitagliptin + Metformin Hydrochloride Tablets 50mg/500mg Rs. 65/-
(4) Sitagliptin + Metformin Hydrochloride Tablets 50mg/1000mg Rs. 70/-
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. All these variants are available at 60% to 70% lesser prices than branded variants as they are available in the price band of Rs. 162 to Rs. 258 at other medical stores.
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, more than 8700 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country. These Kendras are selling quality generic medicines, surgical equipment, nutraceuticals and other products. At present, these Kendras make available more than 1600 medicines and 250 surgical devices including Suvidha Sanitary pads which are sold at Re 1 per pad.
The 33rd meeting of the Working Mechanism for Consultation and Coordination on India-China Border Affairs…
Anshuman Gaur, presently serving as Joint Secretary in the Ministry of External Affairs (MEA), has…
The Fashion Design Department of the University of Haifa recently concluded a nine-day study trip…
Union Home Minister Amit Shah on Tuesday hailed the decision of two Hurriyat-affiliated organizations to…
India's defence production has reached a record Rs 1.27 lakh crore in FY 2023-24, the…
The ongoing Diamer-Bhasha Dam protest in Pakistan-occupied Gilgit-Baltistan (PoGB) has entered its 38th consecutive day,…